Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148003 · ClinicalTrials.gov registry record · NA
Effect of the Temperature Used in Thermal Radiofrequency Ablation
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT02148003: Clinical Trial NA study, sponsored by The Cleveland Clinic.
NCT02148003 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02148003, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
This study will determine if lumbar facets medial branches RFA at 90 degrees Celsius provides more overall pain relief (i.e., percent of improvement), when compared to ablation at 80 degrees Celsius with no additional adverse events.
Primary Outcome
The primary outcome was the Visual Analog Scale (VAS) pain score at 30-day follow-up visit, which was collected by patients marking a position on a strip to indicate the intensity of their pain. The locations patients marked are translated into a score from 0-100, with 0 being no pain and 100 corresponding to the worst imaginable pain.
Interventions
- PROCEDURE RFA at 90 degrees Celsius
- PROCEDURE RFA at 80 degrees Celsius
- DEVICE C-arm guided 20-gauge radiofrequency needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2014-05 |
| Est. Completion | 2022-09 |
| Phase | NA |
Why NCT02148003 stopped before completion
NCT02148003 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which RFA at 90 degrees Celsius is the first listed.
NCT02148003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02148003 about?
NCT02148003 is a clinical study titled "Effect of the Temperature Used in Thermal Radiofrequency Ablation". This study will determine if lumbar facets medial branches RFA at 90 degrees Celsius provides more overall pain relief (i.e., percent of improvement), when compared to ablation at 80 degrees Celsius with no additional adverse events.
What is the current status of trial NCT02148003?
This trial is currently terminated. It is a NA study. The enrollment target is 199 participants. The study started on 2014-05. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02148003?
The interventions under investigation include: RFA at 90 degrees Celsius (PROCEDURE), RFA at 80 degrees Celsius (PROCEDURE), C-arm guided 20-gauge radiofrequency needle (DEVICE).
Who is sponsoring clinical trial NCT02148003?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02148003's enrollment target sits among peer trials
199 567th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia